A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2001
11/22/2001	WO2001087282A2 Pepsin inhibition by alginates
11/22/2001	WO2001087234A2 Treatment of autoimmune, proliferative and inflammatory diseases with compositions of non-ionic copolymers
11/22/2001	WO2001087085A1 Growth promoter for animals
11/22/2001	WO2001046128A3 Tryptase inhibitors
11/22/2001	WO2001042246A3 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
11/22/2001	WO2001041535A3 Eplerenone crystalline form
11/22/2001	WO2001032691A8 Hcv ns3 protease inhibitors
11/22/2001	WO2001030781A3 INHIBITORS OF αLβ2 MEDIATED CELL ADHESION
11/22/2001	WO2001014564A3 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby
11/22/2001	WO2000014263A9 Recombinant hepatitis a virus (hav), hav variants, hav-based vaccines and methods of producing them
11/22/2001	US20010044544 Useful as high energy oxidizing agents in explosive and propellant formulations, and drugs for vasodilation
11/22/2001	US20010044538 Mitogen-activated protein (MAP) kinase; treating inflammatory diseases; compounds such as 3-(4-fluorophenyl)-1-hydroxy-2-(pyridin-4-yl)-1H-pyrrolo(3,2-b)pyridine
11/22/2001	US20010044523 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
11/22/2001	US20010044519 Bile sequestering polymer comprises a crosslinked, alkylated, cationic polyamine or polyallylamine homo- or co-polymer
11/22/2001	US20010044471 Hydrogenation of racemic 6-alkoxy-1H-indene-1,2(3H)-dione-2-oxime, with chiral acid, resolution, alkylation, bromination, carboxamidation
11/22/2001	US20010044450 5-HT3 receptor antagonists such as alosetron to treat nonconstipated female irritable bowel syndrome
11/22/2001	US20010044421 Antimutagenic compositions for treatment and prevention of photodamage to skin
11/22/2001	US20010044419 Administering to skin a composition containing deoxyribonucleosides in concentrations sufficient to enhance DNA repair or reduce mutation frequency in a vehicle capable of delivering deoxyribonucleosides to skin cells
11/22/2001	US20010044120 Useful for the prevention or treatment of peptic ulcers in humans or mammals.
11/22/2001	US20010043908 Liquid oral compositions comprising a calcium compound and an acidulant
11/22/2001	DE10023484A1 New 2-((cycloalkyl- or heterocyclyl-alkyl)-amino)-benzamide derivatives, are VEGF receptor, KDR kinase and FLT kinase inhibitors useful e.g. for treating tumors, psoriasis, arthritis or renal or ophthalmological diseases
11/22/2001	DE10020667A1 Neue Benzoxazin- und Benzothiazin-Derivate und deren Verwendung in Arzneimitteln New benzoxazine and benzothiazine derivatives and their use in medicaments
11/22/2001	CA2781858A1 Modulators of tnf-.alpha. signaling
11/22/2001	CA2762960A1 Recrystallization processes for obtaining anhydrous optically active lansoprazole
11/22/2001	CA2410091A1 Piperidyindoles as serotonin receptor ligands
11/22/2001	CA2410077A1 Cyclohexyl derivatives and their use as therapeutic agents
11/22/2001	CA2410013A1 Pepsin inhibition by alginates
11/22/2001	CA2409740A1 Novel aryl, alkenyl, and alkynyl 4-dedimethylaminotetracycline desrivatives
11/22/2001	CA2409258A1 Novel amorphous form of omeprazole salts
11/22/2001	CA2409116A1 Substituted thioacetamides
11/22/2001	CA2409044A1 Improved recrystallization processes for obtaining anhydrous optically active lansoprazole
11/22/2001	CA2409035A1 Hydroxamic acid derivatives
11/22/2001	CA2408849A1 Cyclohexane derivatives and their use as therapeutic agents
11/22/2001	CA2408745A1 Anti-angiogenic polypeptides
11/22/2001	CA2408617A1 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
11/22/2001	CA2408513A1 Immunomodulatory human mhc class ii antigen-binding polypeptides
11/22/2001	CA2408408A1 Modulators of tnf- alpha signaling
11/22/2001	CA2408373A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors
11/22/2001	CA2408360A1 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
11/22/2001	CA2407469A1 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
11/22/2001	CA2407258A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
11/22/2001	CA2406013A1 Treatment of autoimmune, proliferative and inflammatory diseases with compositions of non-ionic copolymers
11/21/2001	EP1156110A2 G-protein coupled receptor (HFGAN72Y)
11/21/2001	EP1156049A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them
11/21/2001	EP1156039A1 Pyridazin-3-one derivatives and medicines containing the same
11/21/2001	EP1155695A1 1,3 oxathiolane nucleoside analogues
11/21/2001	EP1155691A2 Anti-angiogenic compositions and methods of use
11/21/2001	EP1155690A2 Anti-angiogenic compositions and method of use
11/21/2001	EP1155689A2 Anti-angiogenic compositions and methods of use
11/21/2001	EP1155623A1 Growth promoter for animals
11/21/2001	EP1155000A1 2-aminopyridines containing fused ring substituents
11/21/2001	EP1154993A1 Thioamide derivatives
11/21/2001	EP1154988A1 Mevinolin derivatives
11/21/2001	EP1154987A1 Phenylalaninol derivatives
11/21/2001	EP1154786A2 Methods and compositions for altering mucus secretion
11/21/2001	EP1154781A1 Preparation for regulating lower bowel function
11/21/2001	EP1154780A2 Bone marrow transplantation for hepatic regeneration and repair
11/21/2001	EP1154771A1 Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use
11/21/2001	EP1154769A1 A novel anti-angiogenic agent comprising at least one kringle region and an upstream pre-activation domain of plasminogen
11/21/2001	EP1154768A1 Gabapentin derivative for preventing and treating visceral pain
11/21/2001	EP1154765A1 Effervescent laxatives
11/21/2001	EP0998292B1 Method for inhibiting bone resorption
11/21/2001	EP0958277B1 Nitric oxide synthase inhibitors
11/21/2001	EP0914319B1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
11/21/2001	EP0832082B1 N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists
11/21/2001	EP0745081B1 indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase
11/21/2001	CN1323346A TPL-2/COT kinase and methods of use
11/21/2001	CN1323316A 丙型肝炎三肽抑制剂 Tripeptide inhibitor of hepatitis C
11/21/2001	CN1323309A Phenyl yanthine derivatives
11/21/2001	CN1323308A New compounds
11/21/2001	CN1323301A Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
11/21/2001	CN1323291A Diaminopropionic acid derivatives
11/21/2001	CN1323225A Polymer conjugates of interferon beta-1a and their uses
11/21/2001	CN1323209A Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
11/21/2001	CN1323206A Fumaric acid microtablets
11/21/2001	CN1323202A Sertraline oral concentrate
11/21/2001	CN1323200A New oral formulation for 5-HT4 agonists or antagonists
11/21/2001	CN1323181A Method and device for preparing a dental implant by immersion in a mesenchymal cell culture
11/21/2001	CN1323165A Protein material for slow digestion and its use
11/21/2001	CN1322762A Humanized antibody with specificity to HBV surface antigen PRE-S1 and its producing process
11/21/2001	CN1322566A Medicine for treating stomatopathy and throat disease
11/21/2001	CN1322561A Chinese medicine for treatig hepatitis B
11/21/2001	CN1322551A Preparation of toothache treating medicated gargle wine
11/21/2001	CN1322549A Oral medicine for treating spleen and stomach disease
11/21/2001	CN1322536A Laxative and its preparation
11/21/2001	CN1322534A Hepatitis treating Chinese medicine and its preparation
11/21/2001	CN1322533A Chinese medicine composition preparation for treating alveolysis
11/21/2001	CN1322527A Dysentery treating medicine
11/21/2001	CN1075113C Realignment protein of human digestive enzyme and process for their preparation
11/21/2001	CN1075112C Producing process of HEV Protein and method of testing HEV infection
11/21/2001	CN1074924C Preparing method for medical composition containing 1,3-oxathiolane nucleoside analogues
11/20/2001	US6320037 IBD-associated microbial nucleic acid molecules
11/20/2001	US6319922 Propanoic acid derivatives
11/20/2001	US6319921 Aromatic heterocyclic compound as antiinflammatory agents
11/20/2001	US6319920 Muscarinic receptor antagonist used in gastrointestinal, genitourinary tract, respiratory tract, cardiovascular system, central nervous system disorders and in anesthesiology and ophthalmology
11/20/2001	US6319917 Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists
11/20/2001	US6319910 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha
11/20/2001	US6319686 Nucleotide sequences coding binding protein; for use as diagnostic, drug design and therapeutic tools
11/20/2001	US6319513 Oral liquid mucoadhesive compounds
11/20/2001	US6319510 Pad to be installed on gum comprising nonporous layer, adjacent layer retaining medication capable of being liquefied by saliva, semipermeable layer covering second layer and sealed to first layer to form pocket enclosing second layer

1 ... 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 ... 1258